Citation: E. Hamed et A. Sakr, Application of multiple response optimization technique to extended release formulations design, J CONTR REL, 73(2-3), 2001, pp. 329-338
Citation: A. Sakr et M. Andheria, A comparative multidose pharmacokinetic study of buspirone extended-release tablets with a reference immediate-release product, J CLIN PHAR, 41(8), 2001, pp. 886-894
Authors:
Touma, EH
Rashed, MS
Vianey-Saban, C
Sakr, A
Divry, P
Gregersen, N
Andresen, BS
Citation: Eh. Touma et al., A severe genotype with favourable outcome in very long chain acyl-CoA dehydrogenase deficiency, ARCH DIS CH, 84(1), 2001, pp. 58-60
Citation: Sr. Cammarn et A. Sakr, Predicting dissolution via hydrodynamics: salicylic acid tablets in flow through cell dissolution, INT J PHARM, 201(2), 2000, pp. 199-209
Citation: M. Kartal et al., Liquid chromatographic method for the analysis of buspirone HCl and its potential impurities, J CHROM SCI, 38(4), 2000, pp. 151-156
Citation: O. Neumerkel et al., Studies of the production and testing of fluidized-bedrotor granules with modified release, PHARMAZIE, 54(11), 1999, pp. 837-839
Citation: A. Khedr et A. Sakr, Stability-indicating high-performance liquid chromatographic assay of buspirone HCl, J CHROM SCI, 37(12), 1999, pp. 462-468